Shanghai StairMed Technology has secured 350 million yuan ($48.3 million) in a Series B funding round led by several healthcare-focused investors, including Qiming Venture Partners, OrbiMed Healthcare Fund Management, and Lilly Asia Ventures.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in